BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17012977)

  • 1. Symptomatic hypokalemia associated with infliximab in a patient with Crohn's disease.
    Karamanolis G; Tzathas C; Triantafyllou K; Tsiamoulos Z; Ladas S
    Inflamm Bowel Dis; 2006 Oct; 12(10):1010-1. PubMed ID: 17012977
    [No Abstract]   [Full Text] [Related]  

  • 2. Exacerbation of Crohn's disease as paradoxical effect of infliximab.
    Tursi A; Papa A
    J Crohns Colitis; 2012 Apr; 6(3):396. PubMed ID: 22405184
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab.
    Moum B; Konopski Z; Tufteland KF; Jahnsen J
    Inflamm Bowel Dis; 2007 Dec; 13(12):1584-6. PubMed ID: 17663423
    [No Abstract]   [Full Text] [Related]  

  • 4. A rare case of pericarditis, complication of infliximab treatment for Crohn's disease.
    Devasahayam J; Pillai U; Lacasse A
    J Crohns Colitis; 2012 Jul; 6(6):730-1. PubMed ID: 22465046
    [No Abstract]   [Full Text] [Related]  

  • 5. Colon cancer after infliximab therapy for Crohn's disease.
    Ferreira F; Lopes S; Macedo G
    BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 8. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis.
    Wermuth J; Kind F; Steuerwald M
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):A28. PubMed ID: 19187898
    [No Abstract]   [Full Text] [Related]  

  • 9. Abdominal pain due to cholecystitis as first sign of septic salmonellosis in a patient with Crohn's disease on infliximab.
    Kukiolka T; Neurath MF; Mudter J
    Inflamm Bowel Dis; 2011 Jun; 17(6):E48-9. PubMed ID: 21472825
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of psoriasis induced by infliximab treatment for Crohn's disease].
    Jwa YJ; Kim NH; Park HJ; Park JS; Bae WK; Kim KA; Lee JS; Moon YS
    Korean J Gastroenterol; 2010 Nov; 56(5):324-8. PubMed ID: 21099241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.
    Doyle A; Forbes G; Kontorinis N
    J Crohns Colitis; 2011 Jun; 5(3):253-5. PubMed ID: 21575891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term study of infliximab treatment for Crohn's disease in China.
    Zheng JJ; Zhi P; Wang YM; Zhu F; Gu W; Xing YC; Zhou CL; Shen BW
    J Dig Dis; 2011 Apr; 12(2):105-9. PubMed ID: 21401895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic tuberculosis in a patient with Crohn's disease on infliximab: case report.
    Cappello M; Randazzo C; Rizzuto G; Bonura C; Di Vita G; Galia M
    Inflamm Bowel Dis; 2010 Mar; 16(3):368-70. PubMed ID: 19591134
    [No Abstract]   [Full Text] [Related]  

  • 14. Case report of aseptic meningitis in a patient with Crohn's disease under infliximab therapy.
    Manthey C; Lohse AW; Pace A
    Inflamm Bowel Dis; 2011 Feb; 17(2):E10. PubMed ID: 20848497
    [No Abstract]   [Full Text] [Related]  

  • 15. Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial.
    Van Assche G; Vermeire S; Ballet V; Gabriels F; Noman M; D'Haens G; Claessens C; Humblet E; Vande Casteele N; Gils A; Rutgeerts P
    Gut; 2012 Feb; 61(2):229-34. PubMed ID: 21948942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of Crohn's disease by infliximab. About 20 cases].
    Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityrosporum folliculitis in a Crohn's disease patient receiving infliximab.
    Nasir A; El Bahesh E; Whitten C; Lawson A; Udall JN
    Inflamm Bowel Dis; 2010 Jan; 16(1):7-8. PubMed ID: 19504618
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
    Salar A; Bessa X; Muñiz E; Monfort D; Besses C; Andreu M
    Gut; 2007 Aug; 56(8):1169-70. PubMed ID: 17344276
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab prevents Crohn's disease recurrence after ileal resection.
    Regueiro M; Schraut W; Baidoo L; Kip KE; Sepulveda AR; Pesci M; Harrison J; Plevy SE
    Gastroenterology; 2009 Feb; 136(2):441-50.e1; quiz 716. PubMed ID: 19109962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory polypoid mass treated with Infliximab in a Crohn's disease patient.
    Liatsos C; Kyriakos N; Panagou E; Karagiannis S; Salemis N; Mavrogiannis C
    J Crohns Colitis; 2010 Dec; 4(6):707-8. PubMed ID: 21122587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.